| PERIOD ENDING |
31-Oct-09 |
31-Jul-09 |
30-Apr-09 |
31-Jan-09 |
| Total Revenue |
30,950,000 |
27,451,000 |
27,351,000 |
28,800,000 |
| Cost of Revenue |
23,851,000 |
20,855,000 |
20,835,000 |
21,983,000 |
|
| Gross Profit |
7,099,000 |
6,596,000 |
6,516,000 |
6,817,000 |
|
| Operating Expenses |
| Research Development |
704,000 |
667,000 |
716,000 |
732,000 |
| Selling General and Administrative |
2,966,000 |
2,874,000 |
2,794,000 |
2,979,000 |
| Non Recurring |
99,000 |
421,000 |
169,000 |
200,000 |
| Others |
400,000 |
379,000 |
380,000 |
412,000 |
| |
| Total Operating Expenses |
4,169,000 |
4,341,000 |
4,059,000 |
4,323,000 |
|
|
| Operating Income or Loss |
2,930,000 |
2,255,000 |
2,457,000 |
2,494,000 |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net |
-
|
194,000 |
(194,000) |
-
|
| Earnings Before Interest And Taxes |
2,209,000 |
2,449,000 |
2,263,000 |
2,494,000 |
| Interest Expense |
(840,000) |
452,000 |
156,000 |
232,000 |
| Income Before Tax |
3,049,000 |
1,997,000 |
2,107,000 |
2,262,000 |
| Income Tax Expense |
601,000 |
355,000 |
391,000 |
408,000 |
| Minority Interest |
-
|
-
|
-
|
-
|
| |
| Net Income From Continuing Ops |
2,448,000 |
1,642,000 |
1,716,000 |
1,854,000 |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income |
2,448,000 |
1,642,000 |
1,716,000 |
1,854,000 |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares |
$2,448,000 |
$1,642,000 |
$1,716,000 |
$1,854,000 |
|
Help
Income Statement
Reuters offers more in-depth